Dr. Katharina Sophia Volz is the founder of OccamzRazor, a biotech company that uses machine learning to discover treatments for brain diseases, including Parkinson’s. She is now its executive chair and VP of partnerships. OccamzRazor has worked with or received grants from the Michael J. Fox Foundation and the Sergey Brin Family Foundation.

She earned Stanford University’s first PhD in Stem Cell Biology and Regenerative Medicine, finishing in 2012 in two and a half years, and has more than 16 years of biomedical research experience at institutions including Harvard, UCLA, HHMI, Ohio State and Stanford.

Forbes named her to its 2017 30 Under 30 list in science, and MIT Technology Review named her one of its Innovators Under 35. She was a United Nations Women’s Entrepreneurship Day fellow in 2015.

Katharina Sophia Volz is featured in the lineup for the WEDO2015 Summit. Learn more about the Women’s Entrepreneurship Day Organization (WEDO).